메뉴 건너뛰기




Volumn 50, Issue 5, 2012, Pages 529-532

Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria

Author keywords

Antifungal susceptibilities; Candida species; Nosocomial candiduria

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; VORICONAZOLE;

EID: 84862195489     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.618996     Document Type: Article
Times cited : (28)

References (18)
  • 3
    • 34247553866 scopus 로고    scopus 로고
    • C andida urinary tract infections: Treatment options
    • Malani AN, Kauffman CA. C andida urinary tract infections: treatment options. Expert Rev Anti Infect Ther 2007; 5 : 77-84.
    • (2007) Expert Rev Anti Infect Ther , vol.5 , pp. 77-84
    • Malani, A.N.1    Kauffman, C.A.2
  • 4
    • 38149113737 scopus 로고    scopus 로고
    • C andida , Cryptococcus , and other yeasts of medical importance
    • Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, 9th ed. Washington, DC: ASM Press
    • Hazen KC, Howell SA. C andida , Cryptococcus , and other yeasts of medical importance. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, (eds). Manual of Clinical Microbiology , 9th ed. Washington, DC: ASM Press; 2007: 1762-1788.
    • (2007) Manual of Clinical Microbiology , pp. 1762-1788
    • Hazen, K.C.1    Howell, S.A.2
  • 5
    • 84862207667 scopus 로고    scopus 로고
    • Monomorphic yeasts and yeastlike organisms
    • 3th ed. Washington, DC: ASM Press
    • Larone DH. Monomorphic yeasts and yeastlike organisms. In: Medically Important Fungi : A Guide to Identifi cation, 3th ed. Washington, DC: ASM Press, 2002: 21-23.
    • (2002) Medically Important Fungi : A Guide to Identifi Cation , pp. 21-23
    • Larone, D.H.1
  • 6
    • 62949225044 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute, approved standard, Document M27-A3, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute
    • Clinical and Laboratory Standards Institute. R eference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts , approved standard, Document M27-A3, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
    • (2008) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts
  • 7
    • 62949225044 scopus 로고    scopus 로고
    • Clinical and Laboratory Standards Institute. Informational supplement, Document M27-S3, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute
    • Clinical and Laboratory Standards Institute. R eference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts . Informational supplement, Document M27-S3, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
    • (2008) R Eference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts
  • 8
    • 70349648602 scopus 로고    scopus 로고
    • In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods
    • Diekema DJ, Messer SA, Boyken LB, e t al . In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 2009; 47 : 3170-3177.
    • (2009) J Clin Microbiol , vol.47 , pp. 3170-3177
    • Diekema, D.J.1    Messer, S.A.2    Boyken, L.B.3
  • 14
    • 78049239332 scopus 로고    scopus 로고
    • Antifungal agents
    • Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, 9th ed. Washington, DC: ASM Press
    • Ar ? kan S, Rex JH. Antifungal agents. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, (eds). Manual of Clinical Microbiology , 9th ed. Washington, DC: ASM Press; 2007: 1949-1960.
    • (2007) Manual of Clinical Microbiology , pp. 1949-1960
    • Ar Kan, S.1    Rex, J.H.2
  • 15
    • 60549098868 scopus 로고    scopus 로고
    • Clinical practice guideline for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
    • Pappas PG, Kauffman CA, Andes D, et al . Clinical practice guideline for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48 : 503-535.
    • (2009) Clin Infect Dis , vol.48 , pp. 503-535
    • Pappas, P.G.1    Kauffman, C.A.2    Andes, D.3
  • 16
    • 0242268547 scopus 로고    scopus 로고
    • Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: Further favorable experience
    • DOI 10.1046/j.1469-0691.2003.00711.x
    • Fisher JF, Woeltje K, Espinel-Ingroff A, Stanfi eld J, DiPiro JT. Effi cacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience. Clin Microbiol Infect 2003; 9 : 1024-1027. (Pubitemid 37361832)
    • (2003) Clinical Microbiology and Infection , vol.9 , Issue.10 , pp. 1024-1027
    • Fisher, J.F.1    Woeltje, K.2    Espinel-Ingroff, A.3    Stanfield, J.4    DiPiro, J.T.5
  • 17
    • 5444272819 scopus 로고    scopus 로고
    • Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus
    • DOI 10.1128/JCM.42.10.4419-4431.2004
    • Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42 : 4419-4431. (Pubitemid 39362350)
    • (2004) Journal of Clinical Microbiology , vol.42 , Issue.10 , pp. 4419-4431
    • Pfaller, M.A.1    Diekema, D.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.